Known targets — ChEMBL curated mechanism
CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.56 |
| ▸ | CA3 | P07451 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | CA5A | P35218 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.56 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL22581605 | 0.97 | GAA (0.59) | GAACA1CA2CA12CA9 | |
| SCHEMBL8622705 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA9 | |
| SCHEMBL346012 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA9 | |
| SCHEMBL15766180 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA9 | |
| SCHEMBL8943269 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA9 | |
| SCHEMBL16034285 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA9 | |
| SCHEMBL6917577 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA9 | |
| SCHEMBL22615914 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA9 | |
| SCHEMBL20583857 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA9 | |
| SCHEMBL17982097 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109037794-B | Rechargeable battery | 刘小林 | 2020-11-24 | — | — | CN | claimed |
| US-20200343595-A1 | RECHARGEABLE BATTERY | LIU, XIAOLIN (CN) | 2020-10-29 | — | — | US | claimed |
| CN-109037794-A | Rechargeable battery | 南京蔚速科技有限公司 | 2018-12-18 | — | — | CN | claimed |
| US-11377415-B2 | Method for converting N,N-dialkylamide compound into ester compound using complex of fourth-period transition metal as catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-07-05 | — | — | US | disclosed |
| EP-3760607-A1 | METHOD FOR CONVERTING N,N-DIALKYLAMIDE COMPOUND INTO ESTER COMPOUND USING COMPLEX OF FOURTH-PERIOD TRANSITION METAL AS CATALYST | Takasago International Corporation (JP) | 2021-01-06 | — | — | EP | disclosed |
| US-20200399200-A1 | METHOD FOR CONVERTING N,N-DIALKYLAMIDE COMPOUND INTO ESTER COMPOUND USING COMPLEX OF FOURTH-PERIOD TRANSITION METAL AS CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2020-12-24 | — | — | US | disclosed |
| CN-109037794-B | Rechargeable battery | 刘小林 | 2020-11-24 | — | — | CN | disclosed |
| US-20200343595-A1 | RECHARGEABLE BATTERY | LIU, XIAOLIN (CN) | 2020-10-29 | — | — | US | disclosed |
| EP-3503265-A1 | ACTIVE MATERIAL, ELECTRODE, AND POWER STORAGE ELEMENT | Ricoh Company, Ltd. (JP) | 2019-06-26 | — | — | EP | disclosed |
| US-20190190027-A1 | ACTIVE MATERIAL, ELECTRODE, AND POWER STORAGE ELEMENT | RICOH COMPANY, LTD. (JP) | 2019-06-20 | — | — | US | disclosed |
| US-10301424-B2 | Polythiophene derivative, secondary cell positive electrode active material, and secondary cell | RICOH COMPANY, LTD. (JP) | 2019-05-28 | — | — | US | disclosed |
| CN-109037794-A | Rechargeable battery | 南京蔚速科技有限公司 | 2018-12-18 | — | — | CN | disclosed |
| US-9991518-B2 | Polythiophene derivative, method for producing same, positive electrode active material for secondary batteries, and secondary battery | RICOH COMPANY, LTD. (JP) | 2018-06-05 | — | — | US | disclosed |
| US-20170346095-A1 | POLYTHIOPHENE DERIVATIVE, METHOD FOR PRODUCING SAME, POSITIVE ELECTRODE ACTIVE MATERIAL FOR SECONDARY BATTERIES, AND SECONDARY BATTERY | RICOH COMPANY, LTD. (JP) | 2017-11-30 | — | — | US | disclosed |
| EP-3101048-B1 | POLYTHIOPHENE DERIVATIVE, METHOD FOR PRODUCING SAME, POSITIVE ELECTRODE ACTIVE MATERIAL FOR SECONDARY BATTERIES, AND SECONDARY BATTERY | RICOH CO LTD (JP) | 2017-08-30 | — | — | EP | disclosed |
| US-20170158810-A1 | POLYTHIOPHENE DERIVATIVE, SECONDARY CELL POSITIVE ELECTRODE ACTIVE MATERIAL, AND SECONDARY CELL | RICOH COMPANY, LTD. (JP) | 2017-06-08 | — | — | US | disclosed |
| EP-3101048-A1 | POLYTHIOPHENE DERIVATIVE, METHOD FOR PRODUCING SAME, POSITIVE ELECTRODE ACTIVE MATERIAL FOR SECONDARY BATTERIES, AND SECONDARY BATTERY | Ricoh Company, Ltd. (JP) | 2016-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11377415-B2 | Method for converting N,N-dialkylamide compound into ester compound using complex of fourth-period transition metal as catalyst | NEK4, TENT4A, TCF4 | GAA 1393/4885CA1 485/4885CA2 484/4885 |
| US-20200399200-A1 | METHOD FOR CONVERTING N,N-DIALKYLAMIDE COMPOUND INTO ESTER COMPOUND USING COMPLEX OF FOURTH-PERIOD TRANSITION METAL AS CATALYST | NEK4, TENT4A, TCF4 | GAA 1393/4885CA1 485/4885CA2 484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.